Arsenic and type 2 diabetes: Commentary on association of inorganic arsenic exposure with type 2 diabetes mellitus: A meta-analysis by Wang et al.

Journal of Epidemiology and Community Health

Volumn 68, Issue 5, 2014, Pages 393-395

  Becker, Alan ^a   Axelrad, Donald ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER;

CHEMISTRY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HUMAN; META ANALYSIS;

ARSENIC; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING WATER; ENVIRONMENTAL EXPOSURE; HUMANS;

EID: 84899100259     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2013-203463     Document Type: Note

References (39)

1. Wang W, Xie Z, Lin Y, et al. Association of inorganic arsenic exposure with Type 2 Diabetes Mellitus: a meta-analysis. J Epidemiol Community Health 2013;68:176-84.
2. Smith AH, Lopipero PA, Bates MN, et al. Public health, Arsenic epidemiology and drinking water standards. Science 2002;296:2145-6.
3. Jones FT. A broad view of arsenic. Poult Sci 2007;86:2-14.
4. World Health Organization (WHO) Factsheet: Arsenic in drinking water. 2001. http://www.who.int/mediacentre/factsheets/fs372/index.html(accessed 6 Jan 2014).
5. Shaw JE, Sincree RA, Zimmet PZ. Global estimates of prevalence of diabetes for 2010 and 2030. Diabetes Res Clini Pract 2010;87:4-14.
6. American Diabetes Association. Diagnosis and classification of diabetes Mellitus. Diabetes Care 2004;27(Suppl 1):S5-10.
7. Wang SL, Chiou JM, Chen CJ, et al. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect 2003;111:155-9.
8. Li X, Li B, Xi S, et al. Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes. Environ Sci Pollut Res 2013;20:8151-61.
9. Zierold KM, Knobeloch L, Anderson H. Prevalence of chronic diseases in adults exposed to arseniccontaminated drinking water. Am J Public Health 2004;94:1936-37.
10. Lai MS, Hsueh YM, Chen CJ, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994;139:484-92.
11. Islam MR, Khan I, Hassan SN, et al. Association between type 2 diabetes and chronic arsenic exposure in drinking water: A cross sectional study in Bangladesh. Environ Health 2012;11:1-8.
12. Tseng CH, Tai TY, Chong CK, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 2000;108:847-51.
13. Makis KC, Christophi CA, Paisi M, et al. A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus. BMC Public Health 2012;12:1-8.
14. Chen Y, Ahsan H, Stavkovich V, et al. No association between arsenic exposure from drinking water and diabetes mellitus: A cross-sectional study in Bangladesh. Environ Health Perspect 2010;118:1299-305.
15. Coronado-Gonzalez JA, Del Razo LM, Garcia-Vargas G, et al. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res 2007;104:383-9.
16. Gibble MO, Howard BV, Umans JG, et al. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol 2012;176:865-74.
17. Yangh K, Byung-Kook L. Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES 2008. Sci Total Environ 2011;409:4054-62.
18. Rhee SY, Hwang YC, Woo JT, et al. Arsenic exposure and prevalence of diabetes mellitus in Korean Adults. J Korean Med Sci 2012;28:861-8.
19. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Health 2011;10:1-11.
20. Diaz-Villasenor A, Burns AL, Hiriart M, et al. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol 2007;225:123-33.
21. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, et al. Arsenic exposure and prevalence of type 2 diabetes: Updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology 2009;20:1-5.
22. Braunward E, Fauci AS, Kasper D, et al. eds. Harrison's 15th edition principles of internal medicine. New York: Mcgraw-Hill, 2001.
23. Yen CC, Lu FJ, Chen WK, et al. The diabetogenic effects of the combination of humic acid and arsenic: in vitro and in vivo studies. Toxicol Lett 2007;172:91-105.
24. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. National Genet 2010;42:579-89.
25. Walton FS, Harmon AW, Paul DS, et al. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic induced diabetes. Toxicol Appl Pharmacol 2004;198:424-33.
26. Pan W-C, Kile ML, Seow WJ, et al. Genetic susceptible locus in NOTCH2 interacts with arsenic in drinking water on risk of type 2 diabetes. PLOS ONE 2013;8:1-7.
27. Diaz-Villasenor A, Cruz L, Cebrian A, et al. Arsenic Exposure and Calpain-10 polymorphisms impair the function of pancreatic beta-cells in humans: A pilot study of risk factors for T2DM. PLoS ONE 2013;8:1-9.
28. Hou Y, Xue P, Woods CG, et al. Association between arsenic suppression of adiopogenesis and induction of CHOP10 via the endoplasmic reticulum stress response. Environ Health Perspect 2013;121:237-43.
29. Xue P, Hou Y, Zhang Q, et al. Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: Involvement of the adaptive antioxidant response. Biochem Biophys Res Commun 2011;407:360-5.
30. Yang B, Fu J, Zheng H, et al. Deficiency in the nuclear factor E2-related factor 2 renders pancreatic beta-cells vulnerable to arsenic-induced cell damage. Toxicol Appl Pharmacol 2012;264:315-23.
31. Pi J, Zhang Q, Fu J, et al. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 2010;244: 77-83.
32. Diaz-Villasenor A, Burns AL, Salazar AM, et al. Arsenite reduces insulin secretion in rat pancreatic beta-cells by decreasing the calcium-dependent calpain-10 of SNAP-25. Toxicol Appl Pharmacol 2008;231:291-9.
33. Paul DS, Hernandez-Zavala A, Walton FS, et al. Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: Development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol 2007;222:305-214.
34. Paul DS, Walton FS, Saunders RJ, et al. Characterization of the impaired glucose homeostasis produced C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ Health Perspect 2011;119:1104-9.
35. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study the Zimapan and Lagunera regions in Mexico. Environ Health 2011;10:1-11
36. Fowler BA, Madden DF, Chou S, eds. Arsenic, antimony, and Bismuth, Patty's toxicology. 6th edn. New Jersey: Wiley and Sons, 2012.
37. Nava-Acien A, Maull A, Thayer KA, et al. Arsenic and Diabetes. Environ Health Perspect 2013;121:a71-72.
38. Navas-Acien A, Silbergeld EK, Streeter RA, et al. Arsenic exposure and prevalence of type 2 diabetes: a systemic review of the experimental and epidemiological evidence. Environ Health Perspect 2006;114:641-8.
39. Kirk T, Connally R. Arsenic-induced carcinogenesisoxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem Res Toxicol: 2010;13:327-35.